A pre-existing rare PIK3CAE545K subpopulation confers clinical resistance to MEK plus CDK4/6 inhibition in NRAS melanoma and is dependent on S6K1 signaling

Overview of attention for article published in Cancer Discovery, April 2018

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (93rd percentile)

Mentioned by

news: 10 news outlets

twitter: 32 X users

Readers on

mendeley: 73 Mendeley

So far, Altmetric has seen 13 news stories from 10 outlets.

New Targeted Therapy Schedule Could Keep Melanoma at Bay

Health Medicinet, 28 Mar 2018

Medicine, Health Care New Targeted Therapy Schedule Could… Published: March 27, 2018.

New Treatment Could Keep Melanoma at Bay

Medindia, 28 Mar 2018

Optimizing the timing of targeted therapies for melanoma could improve outcomes, revealed research published in Cancer Discovery.

New Targeted Therapy Schedule Could Keep Melanoma at Bay

ALN, 27 Mar 2018

Skin melanoma, a particularly insidious cancer, accounts for the vast majority skin cancer deaths and is one of the most common…

Changing schedules of targeted therapy for melanoma could improve outcomes

The Medical News, 27 Mar 2018

Skin melanoma, a particularly insidious cancer, accounts for the vast majority skin cancer deaths and is one of the most common…

This page shows the most recent news stories that mention this research output. Click here to find out how to access more activity, including 9 additional news stories.